Overview

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of AN2728 Ointment, 5%, compared to Ointment Vehicle, applied twice daily for 12 weeks, in the treatment of plaque type psoriasis
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer